Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study
Clinical Genitourinary Cancer · 2025
DOI: 10.1016/j.clgc.2025.102415 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Genitourinary Cancer, 2025. Verfasst von F Mastroleo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Mil…. Hauptthemen laut MEDLINE: Nomograms, Prostatic Neoplasms, Salvage Therapy, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND/AIM: Salvage radiotherapy (SRT) is a key treatment for biochemical recurrence (BCR) after radical prostatectomy (RP), yet a significant proportion of patients progress to distant metastasis. This multicenter retrospective study aimed to analyze a series of patients who underwent SRT and to develop a predictive nomogram for 5-year-distant-metastasis-free survival (DMFS). MATERIAL AND METHODS: Data were collected from 15 European centers from June 1, 2022, to September 30, 2024. We included SRT patients due to BCR, following RP and no evidence of distant metastases on imaging. A penalized-survival nomogram was developed and internally validated; external validation was performed using data from the largest center. Patients were stratified into low-, intermediate-, and high-risk groups based on tertiles of the predicted risk score distribution. RESULTS: Data from 1,720 SRT patients were analyzed. BCR after SRT occurred in 620 (37%) patients, while clinical recurrence in 494 (30%) patients. Distant metastases were diagnosed in 228 patients (13%). The 2- and 5- years DMFS rates were 93% (95% CI, 92%-95%) and 84% (95% CI, 81%-86%), respectively. Multivariate analysis identified pT3/pT4 stage (HR 1.54 [95% CI, 1.13-2.13], P < .01), ISUP grade group 4/5 (HR 1.75 [95% CI, 1.30-2.35], P < .01), and SRT
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: federico.mastroleo@ieo.it.
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
- Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
- Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Zitieren
APA
Mastroleo, F., Villa, R., Zaffaroni, M., Vincini, M. G., Franzese, C., Nicosia, L., Matrone, F., Donofrio, A., Magli, A., Triggiani, L., Barra, S., Timon, G., Augugliaro, M., Burgio, V., Francolini, G., Hasterok, M., Miszczyk, M., Simoni, N., Spatola, C., …, & Jereczek-Fossa, B. A. (2025). Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2025.102415
Vancouver
Mastroleo F, Villa R, Zaffaroni M, Vincini MG, Franzese C, Nicosia L, et al. Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study. Clinical Genitourinary Cancer. 2025. doi:10.1016/j.clgc.2025.102415
BibTeX
@article{Mastroleo2025,
author = {Mastroleo, F and Villa, R and Zaffaroni, M and Vincini, M G and Franzese, C and Nicosia, L and Matrone, F and Donofrio, A and Magli, A and Triggiani, L and Barra, S and Timon, G and Augugliaro, M and Burgio, V and Francolini, G and Hasterok, M and Miszczyk, M and Simoni, N and Spatola, C and Alongi, F and Arcangeli, S and Scorsetti, M and Marvaso, G and Jereczek-Fossa, B A},
title = {Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study},
journal = {Clinical Genitourinary Cancer},
year = {2025},
doi = {10.1016/j.clgc.2025.102415}
}
EUVIMED